MEDIAN Technologies listed on Top 10 eClinical Trial Management Solutions

We transform medical images into meaningful, actionable insights to help better diagnose, treat, and monitor patients. We deploy proprietary artificial intelligence, computer vision, and signal processing technologies to develop imaging tests and services, addressing life-threatening unmet medical needs.

With eyonis™ we are disrupting the management of serious diseases such as lung cancer, liver cancer, and NASH. We are deploying AI/ML Software as Medical Devices (SaMDs) to help health professionals diagnose patients earlier, treat them more effectively, and bring new hope. eyonis™ is currently under development.

Imaging Services for Clinical Trials

Median’s Imaging CRO business provides leading oncology clinical trial imaging services, empowering our life sciences partners to accelerate the development and delivery of life-saving cancer treatments with unmatched operational excellence and reliability. And we don’t stop there. We are forging the way when it comes to innovative imaging technology, leveraging the latest in AI-powered imaging intelligence to develop actionable insights for biopharma sponsors worldwide.

Learn More

Request a Demo

MEDIAN Technologies listed on Top 10 eClinical Trial Management Solutions

MEDIAN Technologies listed on Pharma Tech Outlook’s Top 10 eClinical Trial Management Solutions of 2016. Fredrik Brag, CEO MEDIAN Technologies, in the related interview, “The cost of developing new drugs is constantly increasing and the whole process needs to be streamlined. New imaging biomarkers and integrated imaging platform play a pivotal role in oncology drug development. That’s where eClinical solutions can help.”

Visit website:

http://www.pharmatechoutlook.com/vendor/article7/median-technologies

Back to press releases